Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Lineage Cell Therapeutics (LCTX) Long-Term Debt Issuances (2016 - 2017)

Lineage Cell Therapeutics' Long-Term Debt Issuances history spans 4 years, with the latest figure at $41000.0 for Q4 2017.

  • For Q4 2017, Long-Term Debt Issuances fell 93.25% year-over-year to $41000.0; the TTM value through Dec 2017 reached $425000.0, down 75.81%, while the annual FY2017 figure was $425000.0, 75.81% down from the prior year.
  • Long-Term Debt Issuances reached $41000.0 in Q4 2017 per LCTX's latest filing, down from $85000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $1.0 million in Q2 2016 to a low of $4000.0 in Q4 2014.
  • Average Long-Term Debt Issuances over 4 years is $258363.6, with a median of $123000.0 recorded in 2017.
  • Peak YoY movement for Long-Term Debt Issuances: skyrocketed 1575.0% in 2015, then tumbled 93.25% in 2017.
  • A 4-year view of Long-Term Debt Issuances shows it stood at $4000.0 in 2014, then surged by 1575.0% to $67000.0 in 2015, then skyrocketed by 805.97% to $607000.0 in 2016, then crashed by 93.25% to $41000.0 in 2017.
  • Per Business Quant, the three most recent readings for LCTX's Long-Term Debt Issuances are $41000.0 (Q4 2017), $85000.0 (Q3 2017), and $176000.0 (Q2 2017).